Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
QTQuanterix Corporation logo

Quanterix Corporation (QTRX)

NASDAQ Global Market · Currency in USD
$2.86 ▲ +0.02 (+0.70%)
At close: Oct 23, 4:00 PM ET. Market closed.
$2.86 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$2.84
Open
$2.82
Day's Range
$2.71 – $2.88
52 Week Range
$2.15 – $8.77
Volume
349,791
Avg. Volume
807,525
Market Cap
$135.26M
Beta (5Y Monthly)
1.01
PE Ratio (TTM)
--
EPS (TTM)
-$2.62
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$3.00

Profile: Quanterix Corporation

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
450
CEO
Everett V. Cunningham

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$0.42 · Revenue est. $33.85M
DateEst.Actual
Aug 10, 2026-$0.41-$1.04Miss
May 6, 2026-$0.31-$0.39Miss
Mar 2, 2026-$0.27-$0.38Miss
Nov 10, 2025-$0.23-$0.73Miss
Aug 7, 2025-$0.41-$0.77Miss
May 12, 2025-$0.69-$0.53Beat

Analyst view

Consensus price target
$3.00 ▲ +4.9%
Range $3.00 – $3.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on QTRX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.